Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Macular spatial distribution of preserved autofluorescence in patients with choroideremia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Early postnatal hyperglycaemia is a risk factor for treatment-demanding retinopathy of prematurity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Deep anterior lamellar keratoplasty: dissection plane with viscoelastic and air can be different

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Multimodal imaging of small hard retinal drusen in young healthy adults

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Clinical and genomic features of adult and paediatric acute leukaemias with ophthalmic manifestations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Global microRNA profiling of metastatic conjunctival melanoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. High-throughput sequencing reveals no viral pathogens in eight cases of ocular adnexal extranodal marginal zone B-cell lymphoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Diagnosis of orbital mass lesions: clinical, radiological, and pathological recommendations

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Association of Choroidal Effusion and Infusion of Daratumumab

    Publikation: Bidrag til tidsskriftLetterForskning

Vis graf over relationer

BACKGROUNDS/AIMS: To date, this is the largest cohort study on extranodal marginal zone B-cell lymphoma (EMZL) of the ocular adnexa (OA). The aim of the study was to characterise the clinical features of OA-EMZL.

METHODS: A retrospective multicentre study involving seven international eye cancer centres. Data were collected from 1 January 1980 through 31 December 2017. A total of 689 patients with OA-EMZL were included.

RESULTS: The median follow-up time was 42 months. The median age was 62 years (range, 8-100 years), and 55 % (378/689 patients) of patients were women. The majority of patients (82%, 558/680 patients) were diagnosed with primary OA-EMZL with Ann Arbor stage IE (90%, 485/541 patients) and American Joint Committee on Cancer stage T2 (61%, 340/557 patients) at the time of diagnosis. The orbit (66%, 452/689 patients) and the conjunctiva (37%, 255/689 patients) were the most frequently involved anatomical structures. The 5-year, 10-year and 20-year disease-specific survival (DSS) were 96%, 91% and 90%, respectively. Stage IE patients treated with external beam radiation therapy (EBRT) as monotherapy (10-year DSS, 95%) were found to have a better DSS than stage IE patients treated with chemotherapy (10-year DSS, 86%). Stage IIIE/IVE patients treated with chemotherapy and rituximab had a better DSS (10-year DSS, 96%) than stage IIIE/IVE patients treated with chemotherapy without rituximab (10-year DSS, 63%).

CONCLUSIONS AND RELEVANCE: EMZL is a slow-growing tumour with an excellent long-term survival. Low-dose EBRT as monotherapy should be considered in localised OA-EMZL. Rituximab-based chemotherapy should be chosen in those patients with disseminated disease.

OriginalsprogEngelsk
TidsskriftThe British journal of ophthalmology
ISSN0007-1161
DOI
StatusUdgivet - 8 jun. 2019

Bibliografisk note

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

ID: 58938715